Cantel Medical Corp/ US1380981084 /
| - - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| -USD | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 3.4 bill.USD | 0.13% | 251.16 |
Fundamentals
| FY 2020 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 0.32 USD | -75.76% |
| EPS Diluted: | 0.32 USD | -75.76% |
| Revenues per Share: | 24.10 USD | 9.63% |
| Book Value per Share: | 17.30 USD | 9.26% |
| Cash Flow per Share: | 3.25 USD | 102.58% |
| Dividend per Share: | 0.11 USD | -47.50% |
| Total | in mill. | |
| Revenues: | 1,016.05 USD | 10.66% |
| Net Income: | 13.71 USD | -75.10% |
| Operating Cash Flow: | 136.86 USD | - |
| Cash and Cash Equivalents: | 277.87 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 251.16 | 147.66 |
| P/S Ratio: | 3.34 | 1.96 |
| P/BV ratio: | 4.64 | 2.73 |
| P/CF Ratio: | 24.76 | 14.56 |
| PEG: | -3.32 | -1.95 |
| Earnings Yield: | 0.40% | 0.68% |
| Dividend Yield: | 0.13% | 0.22% |
| Market Capitalization | ||
| Market Capitalization: | 3.4 bill. USD | 1.99 bill. USD |
| Free Float Market Cap.: | 1.94 bill. USD | 1.13 bill. USD |
| Market Cap. / Employee: | 923,576.7289 USD | 542,976.2404 USD |
| Shares Outstanding: | 42.31 mill. | |
Profitability
| Gross Profit Margin: | 42.91% |
| EBIT Margin: | 4.75% |
| Net Profit Margin: | 1.35% |
| Return on Equity: | 1.88% |
| Return on Assets: | 0.66% |
Financial Strength
| Liquidity I / Cash Ratio: | 154.81% |
| Liquidity II / Quick Ratio: | 237.49% |
| Liquidity III / Current Ratio: | 360.25% |
| Debt / Equity Ratio: | 183.96% |
| Dynam. Debt / Equity Ratio: | 980.70% |
Efficiency
| Employees: | 3,669 |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | 276,927.77 USD |
| Net Income / Employee: | 3,736.17 USD |
| Total Assets / Employee: | 564,664.49 USD |
| * Fiscal Year End: | 2020-07-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
